{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:30:35Z","timestamp":1786120235230,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1097\/ico.0b013e31820ca63f","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T20:01:48Z","timestamp":1317758508000},"page":"1219-1222","source":"Crossref","is-referenced-by-count":36,"title":["Subconjunctival Bevacizumab Immediately After Excision of Primary Pterygium: The First Clinical Trial"],"prefix":"10.1097","volume":"30","author":[{"given":"Abdollah","family":"Shenasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farideh","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solmaz","family":"Shoa-Ahari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Rahimi-Ardabili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohollah Fadaei","family":"Fouladi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210204","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00003226-200307000-00015","article-title":"Decreased pigment epithelium-derived factor and increased vascular endothelial growth factor levels in pterygia.","volume":"22","author":"Jin","year":"2003","journal-title":"Cornea"},{"key":"R2-7-20210204","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1442-9071.1991.tb00661.x","article-title":"Pterygium recurrence rate at the Princess Alexandra Hospital.","volume":"19","author":"Sebban","year":"1991","journal-title":"Aust N Z J Ophthalmol"},{"key":"R3-7-20210204","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00055735-199908000-00011","article-title":"The pathogenesis of pterygia.","volume":"10","author":"Coroneo","year":"1999","journal-title":"Curr Opin Ophthalmol"},{"key":"R4-7-20210204","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/00003226-200110000-00013","article-title":"Expression of vascular endothelial growth factor and inducible nitric oxide synthase in pterygia.","volume":"20","author":"Lee","year":"2001","journal-title":"Cornea"},{"key":"R5-7-20210204","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1167\/iovs.06-1149","article-title":"Prognosis-determinant candidate genes identified by whole genome scanning in eyes with pterygia.","volume":"48","author":"Kuo","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R6-7-20210204","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1136\/bjo.2003.039891","article-title":"Mitomycin C for pterygium: long term evaluation.","volume":"88","author":"Raiskup","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"R7-7-20210204","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ophtha.2005.01.023","article-title":"Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia.","volume":"112","author":"Gebhardt","year":"2005","journal-title":"Ophthalmology"},{"key":"R8-7-20210204","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/sj.eye.6702495","article-title":"Angiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor, and thrombospondin-1.","volume":"21","author":"Aspiotis","year":"2007","journal-title":"Eye (Lond)"},{"key":"R9-7-20210204","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1076\/ceyr.25.1.17.9959","article-title":"Angiogenesis in pterygium: morphometric and immunohistochemical study.","volume":"25","author":"Marcovich","year":"2002","journal-title":"Curr Eye Res"},{"key":"R10-7-20210204","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00417-002-0589-1","article-title":"Connective tissue growth factor in pterygium: simultaneous presence with vascular endothelial growth factor possible contributing factor to conjunctival scarring.","volume":"241","author":"van SG, Aspiotis","year":"2003","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R11-7-20210204","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd1381","article-title":"Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer.","volume":"3","author":"Ferrara","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"R12-7-20210204","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4103\/0301-4738.36474","article-title":"Bevacizumab: off-label use in ophthalmology.","volume":"55","author":"Grisanti","year":"2007","journal-title":"Indian J Ophthalmol"},{"key":"R13-7-20210204","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.ajo.2006.06.066","article-title":"Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma.","volume":"142","author":"Iliev","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R14-7-20210204","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/01.iae.0000246884.76018.63","article-title":"Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study).","volume":"26","author":"Jorge","year":"2006","journal-title":"Retina"},{"key":"R15-7-20210204","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.survophthal.2009.02.004","article-title":"Bevacizumab (Avastin) for the treatment of ocular disease.","volume":"54","author":"Gunther","year":"2009","journal-title":"Surv Ophthalmol"},{"key":"R16-7-20210204","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/bjo.2006.107912","article-title":"Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin).","volume":"91","author":"Manzano","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R17-7-20210204","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/ICO.0b013e3181822615","article-title":"Topical bevacizumab eyedrops for limbal-conjunctival neovascularization in impending recurrent pterygium.","volume":"28","author":"Wu","year":"2009","journal-title":"Cornea"},{"key":"R18-7-20210204","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/ICO.0b013e31818d382d","article-title":"Effect of subconjunctival bevacizumab on primary pterygium.","volume":"28","author":"Teng","year":"2009","journal-title":"Cornea"},{"key":"R19-7-20210204","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00347-009-1936-y","article-title":"Antiangiogenic therapy for pterygium recurrence.","volume":"106","author":"Leippi","year":"2009","journal-title":"Ophthalmologe"},{"key":"R20-7-20210204","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1136\/bjo.2008.155291","article-title":"Treatment of inflamed pterygia or residual pterygial bed.","volume":"93","author":"Mansour","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"R21-7-20210204","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/02713680701799101","article-title":"Subconjunctival bevacizumab injection for corneal neovascularization in recurrent pterygium.","volume":"33","author":"Bahar","year":"2008","journal-title":"Curr Eye Res"},{"key":"R22-7-20210204","first-page":"69","article-title":"Comparing techniques for pterygium surgery.","volume":"3","author":"Alpay","year":"2009","journal-title":"Clin Ophthalmol"},{"key":"R24-7-20210204","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajo.2010.03.006","article-title":"Preoperative subpterygeal injection vs intraoperative mitomycin C for pterygium removal: comparison of results and complications.","volume":"150","author":"Khakshoor","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"R25-7-20210204","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.ajo.2005.12.028","article-title":"Conjunctival autografting combined with low-dose mitomycin C for prevention of primary pterygium recurrence.","volume":"141","author":"Frucht-Pery","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R26-7-20210204","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00003226-200103000-00011","article-title":"Halting pterygium recurrence by postoperative 5-fluorouracil.","volume":"20","author":"Pikkel","year":"2001","journal-title":"Cornea"},{"key":"R27-7-20210204","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1742-1241.2004.00007.x","article-title":"5-fluorouracil vs. beta-irradiation in the prevention of pterygium recurrence.","volume":"58","author":"Bekibele","year":"2004","journal-title":"Int J Clin Pract"},{"key":"R28-7-20210204","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ophtha.2006.02.026","article-title":"Efficacy of subconjunctival 5-fluorouracil and triamcinolone injection in impending recurrent pterygium.","volume":"113","author":"Prabhasawat","year":"2006","journal-title":"Ophthalmology"},{"key":"R29-7-20210204","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.eye.6702480","article-title":"Pterygium treatment using 5-FU as adjuvant treatment compared to conjunctiva autograft.","volume":"22","author":"Bekibele","year":"2008","journal-title":"Eye (Lond)"},{"key":"R30-7-20210204","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1590\/S0004-27492009000200007","article-title":"Safety and efficacy of intraoperative 5-fluorouracil infiltration in pterygium treatment.","volume":"72","author":"Valezi","year":"2009","journal-title":"Arq Bras Oftalmol"},{"key":"R31-7-20210204","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00066-006-1484-1","article-title":"Postoperative irradiation for pterygium: retrospective analysis of 1,253 patients from the Osaka University Hospital.","volume":"182","author":"Isohashi","year":"2006","journal-title":"Strahlenther Onkol"},{"key":"R33-7-20210204","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1097\/ICO.0b013e3181d5d96d","article-title":"Recurrence rate using fibrin glue-assisted ipsilateral conjunctival autograft in pterygium surgery: 2-year follow-up.","volume":"29","author":"Sarnicola","year":"2010","journal-title":"Cornea"},{"key":"R34-7-20210204","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jfo.2009.12.001","article-title":"Limbal-conjunctival autograft in pterygium surgery.","volume":"33","author":"Mery","year":"2010","journal-title":"J Fr Ophtalmol"},{"key":"R35-7-20210204","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1097\/OPX.0b013e3181baac1a","article-title":"Treatment of primary pterygium.","volume":"86","author":"Ozkurt","year":"2009","journal-title":"Optom Vis Sci"},{"key":"R36-7-20210204","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000210444","article-title":"Long-term results of bare sclera, limbal-conjunctival autograft and amniotic membrane graft techniques in primary pterygium excisions.","volume":"223","author":"Ozer","year":"2009","journal-title":"Ophthalmologica"},{"key":"R37-7-20210204","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/ICO.0b013e318158b47f","article-title":"Human amniotic membrane transplantation with fibrin glue in management of primary pterygia: a new tuck-in technique.","volume":"27","author":"Jain","year":"2008","journal-title":"Cornea"},{"key":"R38-7-20210204","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/ICU.0b013e3281a7ecbb","article-title":"Current concepts and techniques in pterygium treatment.","volume":"18","author":"Ang","year":"2007","journal-title":"Curr Opin Ophthalmol"},{"key":"R39-7-20210204","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/08820530902801106","article-title":"Pterygia: pathogenesis and the role of subconjunctival bevacizumab in treatment.","volume":"24","author":"Mauro","year":"2009","journal-title":"Semin Ophthalmol"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003226-201111000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:18:05Z","timestamp":1786047485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003226-201111000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e31820ca63f","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}